about
Enter B and W: two new meningococcal vaccine programmes launchedMeasuring plasma paracetamol concentrations in all patients with drug overdose or altered consciousness: does it change outcome?Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and WalesSafety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyThe immunogenicity of a novel A (H1N1) vaccine in HIV-infected children.Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyChanges in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome.Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.Development and evaluation of detection systems for staphylococcal exfoliative toxin A responsible for scalded-skin syndrome.Staphylococcal scalded skin syndrome.Presentation of vitamin D deficiencyChildhood malaria in East London.Invasive Haemophilus influenzae Disease, Europe, 1996-2006.Supporting decisions to increase the safe discharge of children with febrile illness from the emergency department: a systematic review and meta-analysis.Trends in imported childhood malaria in the UK: 1999-2003.Travel-Associated Salmonella mbandaka Sacroiliac Osteomyelitis in a Healthy Adolescent.Imported malaria in children: a review of clinical studies.Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in EnglandReview of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force.The changing and dynamic epidemiology of meningococcal disease.Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.The burden of nonencapsulated Haemophilus influenzae in children and potential for prevention.The treatment of imported malaria in children: an update.Question 1: Does prophylactic paracetamol prevent fever after vaccination in infants?Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure.Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK cMassive hepatosplenomegaly in a child with malaria.Low back pain at presentation in a newly diagnosed diabetic.The management of established postherpetic neuralgia: a comparison of the quality and content of traditional vs. systematic reviews.Staphylococcal scalded skin syndrome: exfoliative toxin A (ETA) induces serine protease activity when combined with A431 cells.The need for evidence-based management of skin diseases.Leprosy disabilities: the impact of multidrug therapy (MDT).Invasive Haemophilus influenzae serotype e and f disease, England and Wales.Seven-fold increase in viral meningo-encephalitis reports in England and Wales during 2004-2013.Risk of invasive Haemophilus influenzae infection during pregnancy and association with adverse fetal outcomes.Invasive bacterial and fungal infections in paediatric patients with cancer: incidence, risk factors, aetiology and outcomes in a UK regional cohort 2009-2011.Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest London.Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004-11: an observational study.Epidemiology and clinical features of childhood chronic hepatitis B infection diagnosed in England.
P50
Q26775667-E1ECE515-657B-453B-935E-0739E51DA975Q28365241-69DF7068-4ADF-4B80-B0BC-91568FEBCA2CQ28742003-FB928EE5-E236-45D6-BA91-0EB80108F2A2Q28751886-A7B10D70-271B-4189-9D9E-9366DF39BF94Q30404630-C3D28B57-D2FA-4FD9-A349-94E6FC187C43Q30406481-3F8E1B78-877E-4EDA-ACCC-D3F3E1A84C8EQ30412103-1EBB667A-8DDF-4FB5-977C-F37948DC24AFQ33345340-E4EBE7AD-99F7-4A47-9446-3E405FF0EB3FQ33588900-B6EF2455-B6AB-40FC-A40D-D14F4C891337Q33972449-1446E160-D215-4F81-A655-8FDF5296DDBFQ34066214-F59112AA-945C-48DB-9030-6731933DB03FQ35280485-A8006BB2-046F-4016-889C-C09BA2C37758Q35541956-CAFD74CF-2618-4412-9E8F-74F28D9CDCF3Q35877345-463EDCCB-E72A-41DD-9BBA-DD53BBE4E4F0Q35882201-9655BD80-8D8F-40FE-84F5-000EBF29EA40Q36153329-ECA14D6B-1AF9-4AD9-9459-E4E027AAC985Q36757103-EB03FE9C-ED7B-477C-A72D-A656FEA584F2Q36797717-49236300-7F19-464A-9903-D74519ACD8E0Q37672263-15093D34-F712-40E3-AFA8-252602932849Q37944288-2C1967D3-6DD2-4E1E-B732-4B9B9FFBEC30Q37969481-98455A33-B976-425B-A0B2-2BED2A859AC6Q37975608-CCC0C264-44B5-4CD9-965F-559D74298B38Q38007847-015F488D-A85D-45BF-AB38-F24B756B561CQ38061515-148DCBC4-3332-4347-BAE4-87E55E8411D2Q38639588-C54529CB-524B-43F1-A2B9-4512A45FA594Q39109980-87E8FF80-49DB-4B4D-9B6D-7459EBC98C79Q40347033-3327D4D8-D78E-4F3E-883B-B8C3C7686BC9Q40569921-BB1BD3BE-E007-423C-981A-6B9B40C1B81AQ40570005-3D3CCFE0-EA00-4E06-BAF6-1D096F9F9842Q40840666-6E876668-B403-47EA-A6B8-3ECF64A4A1B5Q40935478-C7B81103-0EB3-4845-83CD-06014D64A8FCQ41385702-409A2A24-C571-459F-BCC8-D9B2AEC59D80Q41611606-5324D16F-FABD-4571-9CC8-6E3FB3A7F0DFQ42176219-3B2B6971-88D3-44F4-8D2D-4D8A3DDC607DQ42212680-15A0395B-53C1-4A37-B836-1C4920644413Q42223326-BAC049C5-DB69-4205-A764-42568C8297ACQ42224671-19EBFFAB-7ACE-4993-BDF8-38503180F96AQ42227648-83A3842A-E46D-403A-909D-F56AB143FC25Q42229283-3E5EEB9C-02D2-4FB4-8766-76B3CE0E3681Q42243606-834EC112-DB3C-48C4-8A6E-03CAC0391EEF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Shamez N Ladhani
@ast
Shamez N Ladhani
@en
Shamez N Ladhani
@es
Shamez N Ladhani
@nl
Shamez N Ladhani
@sl
type
label
Shamez N Ladhani
@ast
Shamez N Ladhani
@en
Shamez N Ladhani
@es
Shamez N Ladhani
@nl
Shamez N Ladhani
@sl
prefLabel
Shamez N Ladhani
@ast
Shamez N Ladhani
@en
Shamez N Ladhani
@es
Shamez N Ladhani
@nl
Shamez N Ladhani
@sl
P106
P31
P496
0000-0002-0856-2476